![Clinical Lab Owner Pleads Guilty to Healthcare-Related Scheme](https://www.g2intelligence.com/wp-content/uploads/2022/11/Nov23-2022.News_.WeeklyEnforcementRoundup.ClinicalLabOwnerGuiltyPlea-iStock-1800x1250-1-1080x675.jpg)
Clinical Lab Owner Pleads Guilty to Healthcare-Related Scheme
On Nov. 15, a psychiatrist and clinical lab owner pled guilty to his role in a complicated $3.8 million fraud scheme.
On Nov. 15, a psychiatrist and clinical lab owner pled guilty to his role in a complicated $3.8 million fraud scheme.
While again light on lab-related cases, this week’s healthcare-related enforcement actions featured improper billing, kickbacks, and telemedicine.
Though light on lab-related cases, last week’s enforcement actions cracked down on COVID-19-related violations.
A doctor settles alleged FCA violations involving genetic tests, while a clinical lab owner pleads guilty for his role in another scheme.
Most of the recent settlements and enforcement actions involving labs related to medically unnecessary UDTs and genetic tests.